# Zonisamide Versus Topiramate in Migraine

> **NCT06347497** · PHASE3 · UNKNOWN · sponsor: **Kafrelsheikh University** · enrollment: 600 (estimated)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** Zonisamide 50 MG
- **DRUG:** Topiramate 50 MG

## Key facts

- **NCT ID:** NCT06347497
- **Lead sponsor:** Kafrelsheikh University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04-01
- **Primary completion:** 2025-04-02
- **Final completion:** 2025-05-01
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2024-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06347497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06347497, "Zonisamide Versus Topiramate in Migraine". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06347497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*